CharlieKey takeaways from your favorite podcasts
← 12 November 2026No Priors

Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg

Max Jaderberg argues drug discovery stalls because it is empirical trial and error, and that predictive AI models reaching experimental accuracy can move design onto computers, raising success rates and enabling safer, more complex medicines.

Watch on YouTube ↗

Word for word

The large part of the industry that makes medicines is this very empirically driven process. Where things really fail is in the clinic, because we never could see the problems until we get to the point where we put these drugs in patients and we say, "Oh no, there's toxicity that we didn't account for." And so the really big opportunity is to have much more of that understanding before you go into patients.

Do more with Charlie

Free — sign in with your email, no password.